HEALIUS LIMITED — Director's Dealing 2022

Aug 31, 2022

==> picture [594 x 65] intentionally omitted <==

1 September 2022

The Manager Market Announcements Office ASX Limited Level 4, Bridge Street SYDNEY NSW 2000

Dear Sir/Madam,

HEALIUS LIMITED (ASX:HLS) - CORRECTED APPENDIX 3Ys

I refer to the Appendix 3Ys lodged on 25 October 2021 and 5 July 2022 in respect of Dr Malcolm Parmenter.

It has come to our attention that the Appendix 3Y of 25 October 2021 contained an error which incorrectly listed the number of disposed shares as 143,193 fully paid Ordinary Shares, when the correct number of shares actually disposed of was 154,553 fully paid Ordinary Shares (a difference of 11,360 Shares). Consequently the number of securities held after the change was reported as 633,287 Ordinary Shares when the correct number should have been 621,927 Ordinary Shares.

The above error was carried forward into the Appendix 3Y of 5 July 2022.

The enclosed Appendix 3Ys have been corrected; I will also lodge these corrected 3Ys separately on the Market Announcements Platform. A new Appendix 3Y in respect of Dr Parmenter is to be lodged tomorrow (2 September 2022) and this will also reflect the above corrections.

In an attempt to prevent a recurrence, we have adopted an additional process step to cross check Key Management Personnel (KMP) transaction notifications from our share registry against trade confirmations supplied by KMPs.

Yours sincerely

==> picture [163 x 47] intentionally omitted <==

Charles Tilley Company Secretary

Attached:

Corrected Appendix 3Y dated 25 October 2021 Corrected Appendix 3Y dated 5 July 2022

==> picture [594 x 65] intentionally omitted <==

Appendix 3Y Change of Director’s Interest Notice

Corrected Appendix 3Y Origi ~~nally lodged 8 November 2021~~ Corrected 1 September 2022

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity HEALIUS LIMITED(Company)	Name of entity HEALIUS LIMITED(Company)
ABN	24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Malcolm Parmenter	Name of Director Malcolm Parmenter
Date of last notice	25 October 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [434 x 340] intentionally omitted <==

----- Start of picture text -----

Direct or indirect interest Direct
As shown in relation to ordinary shares
Nature of indirect interest
(including registered holder) Not applicable in relation to Performance Rights
Note: Provide details of the circumstances giving
rise to the relevant interest. Not applicable in relation to Options
Date of change 8 November 2021
Malcolm W Parmenter Pty Ltd
59,597
atf Malcolm W Parmenter
Ordinary shares
Superannuation Fund
776,480
Malcolm Parmenter
Ordinary shares
No. of securities held prior to
change 101,034
Employee Service
Malcolm Parmenter
Rights
11,081,391
Malcolm Parmenter
Options
Class Ordinary shares
Number acquired Nil
----- End of picture text -----

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

==> picture [434 x 311] intentionally omitted <==

----- Start of picture text -----

Number disposed 143,193 154,553 fully paid Ordinary shares
Value/Consideration
Note: If consideration is non-cash, provide details $4.98 per share
and estimated valuation
Malcolm W Parmenter Pty Ltd
59,597
atf Malcolm W Parmenter
Ordinary shares
Superannuation Fund
633,287
621,927 Malcolm Parmenter
No. of securities held after Ordinary shares
change
101,034
Employee Service Malcolm Parmenter
Rights
11,081,391
Malcolm Parmenter
Options
Nature of change On-market trade (during trading window) to meet tax
Example: on-market trade, off-market trade, obligations arising from allocation of securities in
exercise of options, issue of securities under September and October 2021 as part of Dr Parmenter’s
dividend reinvestment plan, participation in buy-
back remuneration package.
----- End of picture text -----

Part 2 – Change of director’s interests in contracts Not applicable

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	Not applicable
If so, was prior written clearance provided to allow the trade to proceed during this period?	Not applicable
If prior written clearance was provided, on what date was this provided?	Not applicable

Authorised by: Charles Tilley Company Secretary

Date: 8 November 2021 Corrected 1 September 2022

[Note: this Appendix 3Y supersedes the Appendix 3Y lodged on 8 November 2021 in respect of Dr Malcolm Parmenter. The number of disposed shares has been corrected from 143,193 fully paid Ordinary shares to 154,553 fully paid Ordinary shares and number of securities held after the change from 633,287 Ordinary Shares to 621,927 Ordinary shares.]

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Corrected Appendix 3Y Origi ~~nally lodged 5 July 2022~~ Corrected 1 September 2022

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity HEALIUS LIMITED(Company)	Name of entity HEALIUS LIMITED(Company)
ABN	24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Malcolm Parmenter	Name of Director Malcolm Parmenter
Date of last notice	08 November 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [434 x 342] intentionally omitted <==

----- Start of picture text -----

Direct or indirect interest Direct
As shown in relation to ordinary shares
Nature of indirect interest
(including registered holder) Not applicable in relation to Performance Rights
Note: Provide details of the circumstances giving
rise to the relevant interest. Not applicable in relation to Options
Date of change 1 July 2022
Malcolm W Parmenter Pty Ltd
59,597
atf Malcolm W Parmenter
Ordinary shares
Superannuation Fund
633,287
621,927 Malcolm Parmenter
Ordinary shares
No. of securities held prior to
change
101,034
Employee Service Malcolm Parmenter
Rights
11,081,391
Malcolm Parmenter
Options
Class Ordinary shares
Number acquired 101,034
----- End of picture text -----

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number disposed		Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation		Nil
		59,597 Ordinary shares Malcolm W Parmenter Pty Ltd atf Malcolm W Parmenter Superannuation Fund
No. of securities held after change		~~734,321~~ 722,961 Ordinary shares Malcolm Parmenter
		11,081,391 Options Malcolm Parmenter
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back		Issue of ordinary shares on vesting of Service Rights awarded under FY 2021 Short Term Incentive Plan (date of shareholder approval 22 October 2020; date of award 20 October 2021; vesting date 1 July 2022).

Part 2 – Change of director’s interests in contracts Not applicable

Part 3 –[+] Closed period

Part 3 –+Closed period	Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required? Not applicable
If so, was prior written clearance provided to allow the trade to proceed during this period? Not applicable
If prior written clearance was provided, on what date was this provided?	Not applicable
Authorised by: Charles Tilley Company Secretary

Date: 5 July 2022 Corrected 1 September 2022

[Note: this Appendix 3Y supersedes the Appendix 3Y lodged on 5 July 2022 in respect of Dr Malcolm Parmenter. The number of securities held prior to and after the change has been corrected from 633,287 Ordinary Shares to 621,927 Ordinary shares.]

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011